IBDEI2NW ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44671,0)
 ;;=A60.9^^200^2230^2
 ;;^UTILITY(U,$J,358.3,44671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44671,1,3,0)
 ;;=3^Anogenital Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,44671,1,4,0)
 ;;=4^A60.9
 ;;^UTILITY(U,$J,358.3,44671,2)
 ;;=^5000359
 ;;^UTILITY(U,$J,358.3,44672,0)
 ;;=A60.04^^200^2230^34
 ;;^UTILITY(U,$J,358.3,44672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44672,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,44672,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,44672,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,44673,0)
 ;;=A60.01^^200^2230^32
 ;;^UTILITY(U,$J,358.3,44673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44673,1,3,0)
 ;;=3^Herpesviral Infection of Penis
 ;;^UTILITY(U,$J,358.3,44673,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,44673,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,44674,0)
 ;;=B00.1^^200^2230^33
 ;;^UTILITY(U,$J,358.3,44674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44674,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,44674,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,44674,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,44675,0)
 ;;=B97.89^^200^2230^89
 ;;^UTILITY(U,$J,358.3,44675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44675,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,44675,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,44675,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,44676,0)
 ;;=B97.10^^200^2230^21
 ;;^UTILITY(U,$J,358.3,44676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44676,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,44676,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,44676,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,44677,0)
 ;;=B34.9^^200^2230^90
 ;;^UTILITY(U,$J,358.3,44677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44677,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,44677,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,44677,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,44678,0)
 ;;=A69.20^^200^2230^50
 ;;^UTILITY(U,$J,358.3,44678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44678,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,44678,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,44678,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,44679,0)
 ;;=A69.22^^200^2230^52
 ;;^UTILITY(U,$J,358.3,44679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44679,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,44679,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,44679,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,44680,0)
 ;;=A69.21^^200^2230^51
 ;;^UTILITY(U,$J,358.3,44680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44680,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,44680,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,44680,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,44681,0)
 ;;=A69.29^^200^2230^18
 ;;^UTILITY(U,$J,358.3,44681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44681,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,44681,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,44681,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,44682,0)
 ;;=A69.23^^200^2230^5
 ;;^UTILITY(U,$J,358.3,44682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44682,1,3,0)
 ;;=3^Arthritis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,44682,1,4,0)
 ;;=4^A69.23
 ;;^UTILITY(U,$J,358.3,44682,2)
 ;;=^5000378
 ;;^UTILITY(U,$J,358.3,44683,0)
 ;;=A51.0^^200^2230^29
 ;;^UTILITY(U,$J,358.3,44683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44683,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,44683,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,44683,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,44684,0)
 ;;=A52.3^^200^2230^54
